Additionally, results indicated that high MMP-2 expression was also associated with adverse clinical prognostic features, including perineural invasion, lymphatic invasion, N stage and carcinoembryonic antigen (CEA) level in COAD patients (Figs. 4C–4F). This evidence concerns the gene MMP2 and colon adenocarcinoma.